Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Trials|December 2, 2022
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)-a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICOA Di Giorgio, C Gerardi, C Abatini, et al.European Journal of Cancer (Oxford, England : 1990)|February 24, 2019
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trialsS Cascinu, D Poli, A Zaniboni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)C Pinto, F Di Fabio, E Maiello, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2013
Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient dataF A Raja, N Counsell, N Colombo, et al.Lung Cancer (Amsterdam, Netherlands)|April 22, 2014
Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committeeR Califano, M V Karamouzis, S Banerjee, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2017
Prognostic factors in Merkel cell carcinoma patients undergoing sentinel node biopsyI Mattavelli, R Patuzzo, V Torri, et al.ESMO Real World Data and Digital Oncology|April 3, 2026
Corrigendum to "Cost-effectiveness of first-line osimertinib informed by electronic medical records via text-mining: a real-world Italian case study of <i>EGFR</i>-mutated advanced NSCLC patients": [ESMO Real World Data and Digital Oncology Volume 10, December 2025, 100198]F Corso, P Baili, F Scotti, et al.Journal of the Neurological Sciences|August 20, 2016
Early effect of dalfampridine in patients with MS: A multi-instrumental approach to better investigate responsivenessL Brambilla, D Rossi Sebastiano, D Aquino, et al.Acta Neurologica Scandinavica|February 19, 2015
Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job)A Raggi, A M Giovannetti, S Schiavolin, et al.Haematologica|September 1, 1996
Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphomaT Lerede, R Bassan, A Rossi, et al.Pageof 11